Background Cytisine is a smoking cessation medication. This systematic review
incorporates recently published randomized controlled trials (RCTs) to provide an updated …

Background and aims Smoking is considered the main cause of preventable death world‐
wide. This study aimed to review the efficacy and safety of cytisine for smoking cessation …

Anxiety is a serious mental disorder, and recent statistics have determined that 35.12% of
the global population had an anxiety disorder during the COVID-19 pandemic. A mechanism …

Background Despite treatment, patients with tuberculosis (TB) who smoke have poorer
outcomes compared with non-smokers. It is unknown, however, if quitting smoking during …

Abstract Background and Aims Cytisine (also known as cytisinicline) is a low‐cost partial
agonist of nicotinic acetylcholine receptors used to assist tobacco cessation. We aimed to …

Background Most people who stop smoking gain weight. This can discourage some people
from making a quit attempt and risks offsetting some, but not all, of the health advantages of …

Background Nicotine receptor partial agonists may help people to stop smoking by a
combination of maintaining moderate levels of dopamine to counteract withdrawal …

There is a growing body of data describing a high burden of respiratory morbidity amongst
pulmonary TB patients and survivors, with up to half thought to experience residual …

Objective: To investigate the antivenom mechanism of cytisine through network
pharmacology and molecular docking (MD) techniques, with the intention of exploring its …

Background Tobacco consumption is a major risk factor for many diseases including
diabetes and has deleterious effects on oral health. Diabetic patients are vulnerable to …